New drug combo shows promise for Tough-to-Treat breast cancer
NCT ID NCT04681768
Summary
This study looked at how well a drug called abemaciclib works when combined with standard hormone therapy for advanced breast cancer that has spread to organs like the liver or lungs. It involved 95 women with significant symptoms or a high amount of cancer in their bodies. The main goal was to collect real-world data on how well this combination controls the cancer and shrinks tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER/ METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Klinikum rechts der Isar der TU München, Klinik und Poliklinik für Frauenheilkunde
Munich, 81675, Germany
Conditions
Explore the condition pages connected to this study.